Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (s)-4-(4-((4-chlorophenyl)(2-pyridil)methoxy)piperidino)butylic Acid Monobenzenesulfonate
2. Betotastine
3. Betotastine Besilate
4. Tau 284
5. Tau-284
1. 125602-71-3
2. Betotastine
3. 190786-43-7
4. (s)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoic Acid
5. Tau 284
6. Hyd2u48ias
7. 4-((4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid
8. 1-piperidinebutanoicacid, 4-[(s)-(4-chlorophenyl)-2-pyridinylmethoxy]-
9. 4-[4-[(s)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic Acid
10. (+)-(s)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric Acid
11. Chebi:71204
12. 1-piperidinebutanoic Acid, 4-[(s)-(4-chlorophenyl)-2-pyridinylmethoxy]-
13. (+)-4-(((s)-p-chloro-alpha-2-pyridylbenzyl)oxy)-1-piperidinebutyric Acid
14. 4-[4-[(s)-(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-ium-1-yl]butanoate
15. (s)-4-[4-[1-(4-chlorophenyl)-1-(2-pyridyl)methoxy]piperidin-1-yl]butyric Acid
16. Bepotastine [inn]
17. Unii-hyd2u48ias
18. Bepotastine [usan:inn]
19. Bepotastina
20. Bepotastinum
21. Bepotastine [mi]
22. Bepotastine (usan/inn)
23. (s)-4-(4-((4-chlorophenyl)(2-pyridil)methoxy)piperidino)butylic Acid
24. Bepotastine [usan]
25. Bepotastine [vandf]
26. Bepotastine [mart.]
27. Schembl29459
28. Bepotastine [who-dd]
29. Gtpl7466
30. Chembl1201758
31. Dtxsid90904947
32. Tqp0323
33. Zinc602128
34. Cs-m1828
35. Cs-m1895
36. Hy-i0021
37. S5940
38. Akos015913983
39. Am84655
40. Ncgc00386356-02
41. Ncgc00386356-05
42. Ac-26366
43. As-72863
44. D09705
45. D72208
46. Ab01565803_02
47. J-519839
48. Q4890915
49. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)-methoxy]piperidino]butanoic Acid
50. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]-butanoic Acid
51. (s)-4-[4-[(4-chlorophenyl)(2-pyridyl)methoxy]piperidino]butanoic Acid
52. 1-piperidinebutanoic Acid, 4-((4-chlorophenyl)-2-pyridinylmethoxy)-
53. 1-piperidinebutyric Acid, (+)-4-(((s)-p-chloro-2-pyridylbenzyl)oxy)-
54. (+)-4-(((s)-p-chloro-.alpha.-2-pyridylbenzyl)oxy)-1-piperidinebutyric Acid
55. (s)-4-(4-((4-chlorophenyl)(pyridin-2-yl)methoxy)piperidin-1-yl)butanoicacid
56. 4-((s)-(4-chlorophenyl)-2-pyridinylmethoxy)-1-piperidinebutanoic Acid
57. 4-{4-[(s)-(4-chlorophenyl)(pyridin-2-yl)methoxy]piperidin-1-yl}butanoic Acid
| Molecular Weight | 388.9 g/mol |
|---|---|
| Molecular Formula | C21H25ClN2O3 |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 8 |
| Exact Mass | 388.1553704 g/mol |
| Monoisotopic Mass | 388.1553704 g/mol |
| Topological Polar Surface Area | 62.7 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 449 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Related Excipient Companies
Excipients by Applications
Parenteral
Solubilizers
Market Place
ABOUT THIS PAGE
45
PharmaCompass offers a list of Sb17504 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sb17504 manufacturer or Sb17504 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sb17504 manufacturer or Sb17504 supplier.
PharmaCompass also assists you with knowing the Sb17504 API Price utilized in the formulation of products. Sb17504 API Price is not always fixed or binding as the Sb17504 Price is obtained through a variety of data sources. The Sb17504 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Sb17504 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sb17504, including repackagers and relabelers. The FDA regulates Sb17504 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sb17504 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Sb17504 supplier is an individual or a company that provides Sb17504 active pharmaceutical ingredient (API) or Sb17504 finished formulations upon request. The Sb17504 suppliers may include Sb17504 API manufacturers, exporters, distributors and traders.
Sb17504 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sb17504 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sb17504 GMP manufacturer or Sb17504 GMP API supplier for your needs.
A Sb17504 CoA (Certificate of Analysis) is a formal document that attests to Sb17504's compliance with Sb17504 specifications and serves as a tool for batch-level quality control.
Sb17504 CoA mostly includes findings from lab analyses of a specific batch. For each Sb17504 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sb17504 may be tested according to a variety of international standards, such as European Pharmacopoeia (Sb17504 EP), Sb17504 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sb17504 USP).
